EpiPen still expensive and critics should go “copulate with themselves,” Mylan chairman thinks
But they, you know, "care about the patient" and stuff.
Tag: Mylan
Mylan CEO Heather Bresch’s hearing on EpiPen was a complete disaster for the company
Congress was not happy with Bresch's or the FDA's answers.